• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FPH
Click for more information
1.98% $34.52

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED - Announcements

Market Cap $20.09B  ! watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
FPHAppendix 3B28/08/13
FPHResults of Meeting27/08/13
FPHAnnual Shareholders Meeting 2013 Presentation27/08/13
FPHChairman's Address to Shareholders27/08/13
FPHFPH Raises Earnings Guidance at 2013 ASMPRICE SENSITIVE27/08/13
FPHNotification of issue of securities26/08/13
FPHAppendix 3B26/08/13
FPHNotification of issue of securities20/08/13
FPHAppendix 3B20/08/13
FPHNotification of issue of securities19/08/13
FPHAppendix 3B19/08/13
FPHNotification of Issue of Securities19/08/13
FPHAppendix 3B19/08/13
FPHNotification of Issue of Securities16/08/13
FPHAMENDED APPENDIX 3B16/08/13
FPHAppendix 3B16/08/13
FPHCeasing to be a substantial holder15/08/13
FPHAppendix 3B12/08/13
FPHNotification of Issue of Securities12/08/13
FPHNotification of Issue of Securities09/08/13
FPHAppendix 3B09/08/13
FPHNotification of Issues of Securities08/08/13
FPHAppendix 3B08/08/13
AMP +Ceasing to be a substantial holder07/08/13
FPHNotification of Issue of Securities06/08/13
FPHNOTIFICATION OF ISSUE OF SECURITIES06/08/13
FPHInitial Disclosure Director Relevant Interests01/08/13
FPHInitial Directors Interest Notice01/08/13
FPHNotification of Issue of Securities29/07/13
FPHAppendix 3B29/07/13
FPHNotification of Issue of Securities22/07/13
FPHAppendix 3B22/07/13
FPHNotification of Issue of Securities19/07/13
FPHAppendix 3B19/07/13
FPHNOTIFICATION OF ISSUE OF SECURITIES17/07/13
FPHAppendix 3B17/07/13
FPHNotification of Issue of Securities15/07/13
FPHAppendix 3B15/07/13
FPHChange of Director's Interest Notice12/07/13
FPHNotification of Issue of Securities12/07/13
FPHAppendix 3B12/07/13
FPHNotification of Issue of Securities11/07/13
FPHAppendix 3B11/07/13
FPHNotification of Issue of Securities10/07/13
FPHAppendix 3B10/07/13
FPHNotification of Issue of Securities09/07/13
FPHAppendix 3B09/07/13
FPHNotification of Issue of Securities05/07/13
FPHAppendix 3B05/07/13
FPHFPH Proxy Form 201305/07/13
FPHNotice of Annual Sharehoders Meeting 201305/07/13
FPH2013 Notice of Annual Meeting and Proxy Form05/07/13
FPHDRP STRIKE PRICE AND AUD FX RATE FOR FINAL DIVIDEND01/07/13
FPHDirector Appointment/Resignation01/07/13
FPHs209 Notice27/06/13
FPHAnnual Review Letter to Shareholders27/06/13
FPHAnnual Report to shareholders27/06/13
FPH2013 Annual Report Annual Review and s209 Notice27/06/13
FPHNotification of Issue of Securities25/06/13
FPHAppendix 3B25/06/13
FPHFPH UBS Australian Healthcare Conference Presentation17/06/13
FPHFPH Presentation to UBS Australian Healthcare Conference17/06/13
FPHNotification of Issue of Securities14/06/13
FPHAppendix 3B14/06/13
FPHFPH Closing Date for Director Nominations14/06/13
AMP +Change in substantial holding from AMP13/06/13
FPHNotification of Issue of Securities13/06/13
FPHAppendix 3B13/06/13
FPHFPH Goldman Sachs Global Health Conference presentation12/06/13
FPHFPH Presentation Goldman Sachs Global Health Conference12/06/13
FPHFPH Presentation to Macquarie Private Wealth Clients12/06/13
FPHFPH Presentation to Macquarie Private Wealth Clients12/06/13
FPHFY 2013 SECOND HALF & FULL YEAR UPDATE27/05/13
FPHFPH PRESENTATION TO ANALYSTS & FUND MANAGERS27/05/13
FPHFPH Reports Record Full Year Net Profit Up 20%23/05/13
FPHPreliminary Final ReportPRICE SENSITIVE23/05/13
FPHChange in substantial holding10/05/13
FPHFPH TO ANNOUNCE FULL YEAR RESULTS ON 23 MAY 201309/05/13
FPHFPH Introduces New Flow Generator Range07/05/13
FPHPrime Minister opens Paykel Building22/03/13
FPHBecoming a substantial holder notices11/03/13
FPHFPH Raises Earnings Guidance Introduces New Full Face MaskPRICE SENSITIVE20/02/13
FPHDisclosure of Director Relevant Interests15/01/13
FPHChange of Director's Interest Notice15/01/13
FPHNotification of Issue of Securities11/01/13
FPHAppendix 3B11/01/13
FPHNotification of Issue of Securities10/01/13
FPHAppendix 3B10/01/13
FPHChange of Director's Interest Notice21/12/12
FPHChange of Director's Interest Notice18/12/12
FPHLapse of Employee Share Options18/12/12
FPHAppendix 3B14/12/12
FPHNotification of Issue of Securities14/12/12
FPHHalf Yearly Report and Accounts14/12/12
FPHCeasing to be a substantial holder12/12/12
FPHDividend Reinvestment Plan Strike Price and AUD FX rate11/12/12
FPHInitial & Change of Director's Interest Notice07/12/12
FPHBecoming a substantial holder notices28/11/12
FPHFPH Half Year Update Presentation26/11/12
FPHFPH Presentation to Analysts and Fund Managers26/11/12
FPHAppendix 3B
28/08/13
FPHResults of Meeting
27/08/13
FPHAnnual Shareholders Meeting 2013 Presentation
27/08/13
FPHChairman's Address to Shareholders
27/08/13
FPHFPH Raises Earnings Guidance at 2013 ASM
27/08/13PRICE SENSITIVE
FPHNotification of issue of securities
26/08/13
FPHAppendix 3B
26/08/13
FPHNotification of issue of securities
20/08/13
FPHAppendix 3B
20/08/13
FPHNotification of issue of securities
19/08/13
FPHAppendix 3B
19/08/13
FPHNotification of Issue of Securities
19/08/13
FPHAppendix 3B
19/08/13
FPHNotification of Issue of Securities
16/08/13
FPHAMENDED APPENDIX 3B
16/08/13
FPHAppendix 3B
16/08/13
FPHCeasing to be a substantial holder
15/08/13
FPHAppendix 3B
12/08/13
FPHNotification of Issue of Securities
12/08/13
FPHNotification of Issue of Securities
09/08/13
FPHAppendix 3B
09/08/13
FPHNotification of Issues of Securities
08/08/13
FPHAppendix 3B
08/08/13
AMP +Ceasing to be a substantial holder
07/08/13
FPHNotification of Issue of Securities
06/08/13
FPHNOTIFICATION OF ISSUE OF SECURITIES
06/08/13
FPHInitial Disclosure Director Relevant Interests
01/08/13
FPHInitial Directors Interest Notice
01/08/13
FPHNotification of Issue of Securities
29/07/13
FPHAppendix 3B
29/07/13
FPHNotification of Issue of Securities
22/07/13
FPHAppendix 3B
22/07/13
FPHNotification of Issue of Securities
19/07/13
FPHAppendix 3B
19/07/13
FPHNOTIFICATION OF ISSUE OF SECURITIES
17/07/13
FPHAppendix 3B
17/07/13
FPHNotification of Issue of Securities
15/07/13
FPHAppendix 3B
15/07/13
FPHChange of Director's Interest Notice
12/07/13
FPHNotification of Issue of Securities
12/07/13
FPHAppendix 3B
12/07/13
FPHNotification of Issue of Securities
11/07/13
FPHAppendix 3B
11/07/13
FPHNotification of Issue of Securities
10/07/13
FPHAppendix 3B
10/07/13
FPHNotification of Issue of Securities
09/07/13
FPHAppendix 3B
09/07/13
FPHNotification of Issue of Securities
05/07/13
FPHAppendix 3B
05/07/13
FPHFPH Proxy Form 2013
05/07/13
FPHNotice of Annual Sharehoders Meeting 2013
05/07/13
FPH2013 Notice of Annual Meeting and Proxy Form
05/07/13
FPHDRP STRIKE PRICE AND AUD FX RATE FOR FINAL DIVIDEND
01/07/13
FPHDirector Appointment/Resignation
01/07/13
FPHs209 Notice
27/06/13
FPHAnnual Review Letter to Shareholders
27/06/13
FPHAnnual Report to shareholders
27/06/13
FPH2013 Annual Report Annual Review and s209 Notice
27/06/13
FPHNotification of Issue of Securities
25/06/13
FPHAppendix 3B
25/06/13
FPHFPH UBS Australian Healthcare Conference Presentation
17/06/13
FPHFPH Presentation to UBS Australian Healthcare Conference
17/06/13
FPHNotification of Issue of Securities
14/06/13
FPHAppendix 3B
14/06/13
FPHFPH Closing Date for Director Nominations
14/06/13
AMP +Change in substantial holding from AMP
13/06/13
FPHNotification of Issue of Securities
13/06/13
FPHAppendix 3B
13/06/13
FPHFPH Goldman Sachs Global Health Conference presentation
12/06/13
FPHFPH Presentation Goldman Sachs Global Health Conference
12/06/13
FPHFPH Presentation to Macquarie Private Wealth Clients
12/06/13
FPHFPH Presentation to Macquarie Private Wealth Clients
12/06/13
FPHFY 2013 SECOND HALF & FULL YEAR UPDATE
27/05/13
FPHFPH PRESENTATION TO ANALYSTS & FUND MANAGERS
27/05/13
FPHFPH Reports Record Full Year Net Profit Up 20%
23/05/13
FPHPreliminary Final Report
23/05/13PRICE SENSITIVE
FPHChange in substantial holding
10/05/13
FPHFPH TO ANNOUNCE FULL YEAR RESULTS ON 23 MAY 2013
09/05/13
FPHFPH Introduces New Flow Generator Range
07/05/13
FPHPrime Minister opens Paykel Building
22/03/13
FPHBecoming a substantial holder notices
11/03/13
FPHFPH Raises Earnings Guidance Introduces New Full Face Mask
20/02/13PRICE SENSITIVE
FPHDisclosure of Director Relevant Interests
15/01/13
FPHChange of Director's Interest Notice
15/01/13
FPHNotification of Issue of Securities
11/01/13
FPHAppendix 3B
11/01/13
FPHNotification of Issue of Securities
10/01/13
FPHAppendix 3B
10/01/13
FPHChange of Director's Interest Notice
21/12/12
FPHChange of Director's Interest Notice
18/12/12
FPHLapse of Employee Share Options
18/12/12
FPHAppendix 3B
14/12/12
FPHNotification of Issue of Securities
14/12/12
FPHHalf Yearly Report and Accounts
14/12/12
FPHCeasing to be a substantial holder
12/12/12
FPHDividend Reinvestment Plan Strike Price and AUD FX rate
11/12/12
FPHInitial & Change of Director's Interest Notice
07/12/12
FPHBecoming a substantial holder notices
28/11/12
FPHFPH Half Year Update Presentation
26/11/12
FPHFPH Presentation to Analysts and Fund Managers
26/11/12
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$34.52 		Change
0.670(1.98%) 		Mkt cap ! $20.09B
Open High Low Value Volume
$34.64 $34.64 $33.84 $13.26M 386.2K

Buyers (Bids)

No. Vol. Price($)
1 585 $34.52
 

Sellers (Offers)

Price($) Vol. No.
$34.54 672 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
Last
$34.42 		  Change
0.670 ( 1.86 %)
Open High Low Volume
$34.00 $34.54 $33.85 114302
Last updated 15.59pm 29/11/2024 ?
FPH (ASX) Chart

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
HotCopper Highlights: Your most watched stocks for Week 48, 2024 Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.